+34 679 490 537info@nanbiosis.com

Posts Taged cascade-characterization-service

NANBIOSIS at the CIBER-BBN X Annual Conference and 1st meeting of the NANBIOSIS SAB

The X Annual Conference of CIBER-BBN, held in Sevilla last 28 and 29 of November, dedicated a Session to NANBIOSIS on Monday afternoon, to which attended national and international representatives of industry and academia users of NANBIOSIS, representatives of EATRIS and members of the Scientific and Technical Advisory Committee of NANBIOSIS, as well as the CIBER-BBN and the CCMIJU researchers.

Jaume Veciana, Scientific of NANBIOSIS and Ángela Fernández Curto, Assistant Deputy Director General for Planning of Scientific and Technological Infrastructures of Spanish Goverment presented the Unique Technical Scientific Infrastructure (ICTS) of CIBER-BBN and JUMISC for the production and characterization of biomaterials, nanomaterials and devices until their preclinical validation. Among the biomedical applications that frame the activity of NANBIOSIS are diagnostic, regenerative medicine and drug administration, as well as its next Cascade Characterization Service for the preclinical evaluation of nanomedicines.

The project “PRONANBIOSIS” funded by the Spanish Ministry of Economy and Competitiveness with a “Network of Excellence” to consolidate the unified management model of NANBIOSIS, to boost its internationalization and strategic positioning as well as to promote a complete nanomaterials characterization cascade service, was also presented and some of the” success stories “of the ICTS where explained.

Since its launch in July 2015, NANBIOSIS has received more than 250 access requests, with an average participation of about 50 competitive projects per year and annual revenues for its services of between 1 and 2 million euros. Among its users, there are more than 100 companies, especially pharmaceutical laboratories, and more than 300 research groups. In addition, its 27 units are involved in several national and European projects, such as BERENICE (nanoformulation of the active to combat Chagas disease), DRIVE (development of a device with pancreatic cells for diabetes treatment) and several public- Former INNPACTO (PHYTEC -Development of bioactive coated medical products for bone regeneration- and VITILIGO -Development of a new advanced therapy drug for the treatment of Vitiligo-), several projects Challenges Collaboration, or the Network of Excellence Pronanbiosis for the promotion and Consolidation of the ICTS, among others.

At the Conference, the NANBIOSIS Scientific Advisory Committee convened to discuss the key actions of its next Strategic Plan, such as the new Cascade Characterization Service for the preclinical evaluation of nanomedicines.

NANBIOSIS at the CIBER-BBN X Annual Conference and 1st meeting of the NANBIOSIS SAB
Read More

X Annual Conference of CIBER-BBN

The next days 28 and 29 of November the X Annual Conference of CIBER-BBN will be held in Seville.

Within this Conference, 3 thematic forums have been organized for clinical translation, where doctors will present the current challenges of diagnosis and treatment in certain diseases and a debate will open between doctors and
researchers to develop research lines and projects aimed at solving those needs.

Taking advantage of the presence of clinical professionals, NANBIOSIS has organized a session dedicated to presenting itself as “Unique technological scientific infrastructure” (ICTS in Spanish) as well as the nodes that are
part of it. Some cases of success and results will be also presented in order to ´make known the services and advantages offered by NANBIOSIS and facilitate the translation of the research developed in the ICTS.

This session will be attended by Ángela Fernández Curto, Assistant Deputy Director General for Planning of Scientific and Technological Infrastructures MINECO who will explain what is and “ICTS”, Jaume Veciana and Jesús Izco, Scientific Director and Coordinator of NANBIOSIS respectively who shall give some general explanations about NANBIOSIS and what has been done in this year of progress since its recognition as ICTS by MINECO,

Finally, The broader part of the session will be led by the following Coordinators or Scientific Directors of the NANBIOSIS Platforms, who will make a brief presentation of each and will present some cases of success:

Also at the Conference, the NANBIOSIS Scientific Advisory Committee will meet to discuss the key actions of its next Strategic Plan, such as the new Cascade Characterization Service for the preclinical evaluation of nanomedicines.

Conference_10th_CIBER-BBN_2016_Nanbiosis.
Read More
Nanbiosis